EMEA Announces Blueprint to Speed New Product Reviews

International Pharmaceutical Regulatory Monitor
KEYWORDS Drug Approvals / EU
A A

The European Medicines Agency (EMEA) has introduced new procedures designed to streamline the way the agency provides scientific advice on investigational medicines and help move them more quickly from the laboratory to the marketplace.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $10.00